Medically reviewed by Michael MacIntyre, MDSchizophrenia medication falls under two main categories: older, first-generation, ...

Depression and anxiety are the most common psychiatric disorders in the world. Around 300 million people suffer from ...

For around 70 years, the treatment of schizophrenia has relied almost entirely on drugs that block dopamine receptors, so Cobenfy's action on cholinergic receptors offers a brand new way to treat ...

In a review study, researchers reported that omega-3 supplements may lessen the severity of schizophrenia symptoms in teens and young adults, especially those with low levels of omega-3s.

Boehringer Ingelheim has taken an option on a family of GPR52 agonist compounds with potential in schizophrenia from Sosei Heptares, in a €755m deal.

As temperatures rise, so does the risk of heat-related illness – especially for people taking certain prescription drugs.

BMY depends on Reblozyl, Opdualag and Breyanzi to offset revenue hits from generics and Medicare Part D impacts.

A Brandon judge is considering going above the Crown’s suggested sentence for a man who pleaded guilty to masturbating in ...

Here’s how it treats schizophrenia and bipolar depression. Skip to main content . Home ; Conditions . ... In both studies, people took either Caplyta or a placebo (a pill with no medicine).

Community Pharmacy England said that, in the last year alone, the Government has issued serious shortage protocols (SSPs) for ...